Published on 23 May 2024 on Simply Wall St. via Yahoo Finance
Are Investors Undervaluing CONMED Corporation (NYSE:CNMD) By 47%?
Key Insights
CONMED's estimated fair value is US$142 based on 2 Stage Free Cash Flow to EquityCONMED is estimated to be 47% undervalued based on current share price of US$75.31 Analyst price target for CNMD is US$92.38 which is 35% below our fair value estimate
Today we will run through one way of estimating the intrinsic value of CONMED Corporation (NYSE:CNMD) by estimating the company's future cash flows and discounting them to their present value. One way to achieve this is by employing the Discounted Cash Flow (DCF) model. There's really not all that much to it, even though it might appear quite complex.